Reduced tyrosine kinase inhibitor dose is predicted to be as effective as standard dose in chronic myeloid leukemia: a simulation study based on phase III trial data

por Fassoni, Artur C., Baldow, Christoph, Roeder, Ingo, Glauche, Ingmar
Publicado 2018

Modeling Patient-Specific CAR-T Cell Dynamics: Multiphasic Kinetics via Phenotypic Differentiation

por Paixão, Emanuelle A., Barros, Luciana R. C., Fassoni, Artur C., Almeida, Regina C.
Publicado 2022

Modelling of immune response in chronic myeloid leukemia patients suggests potential for treatment reduction prior to cessation

por Karg, Elena, Baldow, Christoph, Zerjatke, Thomas, Clark, Richard E., Roeder, Ingo, Fassoni, Artur C., Glauche, Ingmar
Publicado 2022

CARTmath—A Mathematical Model of CAR-T Immunotherapy in Preclinical Studies of Hematological Cancers

por Barros, Luciana R. C., Paixão, Emanuelle A., Valli, Andrea M. P., Naozuka, Gustavo T., Fassoni, Artur C., Almeida, Regina C.
Publicado 2021